Arbutus Biopharma Corp (ABUS)
NASDAQ·Healthcare·Biotechnology
$4.28
-0.23%
Mkt Cap $849.87M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$8.50
Range $8.50 – $8.50
Implied Upside
+98.6%
Consensus $8.50 vs current $4.28
NASDAQ·Healthcare·Biotechnology
$4.28
-0.23%
Mkt Cap $849.87M
No recent rating data.
Price Target (1 analysts)
$8.50
Range $8.50 – $8.50
+98.6%
Consensus $8.50 vs current $4.28